
In this YouTube presentation, Ashley F explains the role of the mitochondrial-derived peptide MOTS‑c as a metabolic distress signal released during exercise, fasting, and cold exposure. She outlines how MOTS‑c activates the AMPK pathway in skeletal muscle, leading to improved insulin sensitivity, enhanced fat oxidation, and greater endurance. The speaker highlights key mouse studies: (1) mice on a high‑fat diet that received MOTS‑c never developed obesity or insulin resistance, and (2) obese, insulin‑resistant mice given MOTS‑c after disease onset showed reversal of both conditions. The narrative suggests that supplementing with exogenous MOTS‑c could replicate these benefits in humans, positioning the peptide as a promising therapeutic target for metabolic health.











